If you include the R&D staff costs it’s about the same as the December quarter.
Advertising and marketing set to double .... which is good.
You’ve got to spend money to make money.
Looks like 2019 is set for some good growth as we hit new markets.
Ann: MedAdvisor Quarterly Report & Appendix 4C, page-4
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $84.31K | 299.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 209547 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 94066 | 1 |
View Market Depth
| Last trade - 12.52pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
